Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4

PHASE4RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
HyperkalemiaDiet ModificationChronic Kidney DiseaseSodium Zirconium Cyclosilicate
Interventions
DRUG

Sodium zirconium cyclosilicate

In the case of hyperkalemia patients will be treated with Sodium zirconium cyclosilicate to allow the continuation of potassium enriched diet. In case hyperkalemia arises in the control group, patients will be treated with Sodium zirconium cyclosilicate as well.

Trial Locations (1)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Leiden University Medical Center

OTHER